XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements Of Changes In Equity - USD ($)
$ in Thousands
Total
Common And Treasury Stock [Member]
Treasury Stock [Member]
Number Of Shares, Net Of Treasury [Member]
Additional Paid-In Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Parent [Member]
Noncontrolling Interest [Member]
Balance, Number of Shares at Jun. 30, 2022   87,215,613 (24,891,292) 62,324,321          
Balance at Jun. 30, 2022 $ 234,920 $ 83 $ (286,951)   $ 327,891 $ 362,737 $ (168,840) $ 234,920 $ 0
Shares repurchased (Note 12) (471)   $ (471)         (471)  
Shares repurchased (in shares) (Note 12)   0 (103,507) (103,507)          
Redeemable Common Stock, Balance at Jun. 30, 2022 79,429                
Restricted stock granted 0             0  
Restricted stock granted, shares   1,394,558   1,394,558          
Exercise of stock options $ 447 $ 0     447     447  
Exercise of stock options, shares 147,326 147,326   147,326          
Stock-based compensation charge (Note 12) $ 5,978       5,978     5,978  
Reversal of stock-based compensation charge (Note 12) (23)       (23)     (23)  
Reversal of stock-based compensation charge (Note 12), shares   (18,798)   (18,798)          
Stock-based compensation charge related to equity-accounted investment (Note 5) (7)       (7)     (7)  
Net loss (23,165)         (23,165)   (23,165) 0
Other comprehensive income (loss) (Note 11) $ (16,714)           (16,714) (16,714) 0
Balance, Number of Shares at Mar. 31, 2023 63,743,900 88,738,699 (24,994,799) 63,743,900          
Balance at Mar. 31, 2023 $ 200,965 $ 83 $ (287,422)   334,286 339,572 (185,554) 200,965 0
Redeemable Common Stock, Balance at Mar. 31, 2023 79,429                
Balance, Number of Shares at Dec. 31, 2022   88,708,191 (24,956,854) 63,751,337          
Balance at Dec. 31, 2022 214,530 $ 83 $ (287,244)   332,537 345,392 (176,238) 214,530 0
Shares repurchased (Note 12) (178)   $ (178)   0     (178)  
Shares repurchased (in shares) (Note 12)     (37,945) (37,945)          
Redeemable Common Stock, Balance at Dec. 31, 2022 79,429                
Restricted stock granted 0             0  
Restricted stock granted, shares   11,806   11,806          
Exercise of stock options 114 $ 0     114     114  
Exercise of stock options, shares   37,500   37,500          
Stock-based compensation charge (Note 12) 1,667       1,667     1,667  
Reversal of stock-based compensation charge (Note 12) (23)       (23)     (23)  
Reversal of stock-based compensation charge (Note 12), shares   (18,798)   (18,798)          
Stock-based compensation charge related to equity-accounted investment (Note 5) (9)       (9)     (9)  
Net loss (5,820)         (5,820)   (5,820) 0
Other comprehensive income (loss) (Note 11) $ (9,316)           (9,316) (9,316) 0
Balance, Number of Shares at Mar. 31, 2023 63,743,900 88,738,699 (24,994,799) 63,743,900          
Balance at Mar. 31, 2023 $ 200,965 $ 83 $ (287,422)   334,286 339,572 (185,554) 200,965 0
Redeemable Common Stock, Balance at Mar. 31, 2023 79,429                
Balance, Number of Shares at Jun. 30, 2023   88,884,532 (25,244,286) 63,640,246          
Balance at Jun. 30, 2023 179,478 [1] $ 83 $ (288,238)   335,696 327,663 (195,726) 179,478 0
Shares repurchased (Note 12) (207)   $ (207)         (207)  
Shares repurchased (in shares) (Note 12)     (53,486) (53,486)          
Redeemable Common Stock, Balance at Jun. 30, 2023 [1] 79,429                
Restricted stock granted 0       0     0  
Restricted stock granted, shares   934,521   934,521          
Exercise of stock options $ 71 $ 0     71     71  
Exercise of stock options, shares 23,217 23,217   23,217          
Stock-based compensation charge (Note 12) $ 5,782       5,782     5,782  
Reversal of stock-based compensation charge (Note 12) (129)       (129)     (129)  
Reversal of stock-based compensation charge (Note 12), shares   (77,668)   (77,668)          
Stock-based compensation charge related to equity-accounted investment (Note 5) (133)       (133)     (133)  
Net loss (12,405)         (12,405)   (12,405) 0
Other comprehensive income (loss) (Note 11) $ 630           630 630 0
Balance, Number of Shares at Mar. 31, 2024 64,466,830 89,764,602 (25,297,772) 64,466,830          
Balance at Mar. 31, 2024 $ 173,087 $ 83 $ (288,445)   341,287 315,258 (195,096) 173,087 0
Redeemable Common Stock, Balance at Mar. 31, 2024 79,429                
Balance, Number of Shares at Dec. 31, 2023   89,738,784 (25,295,261) 64,443,523          
Balance at Dec. 31, 2023 180,723 [1] $ 83 $ (288,436)   339,149 319,305 (189,378) 180,723 0
Shares repurchased (Note 12) (9)   $ (9)         (9)  
Shares repurchased (in shares) (Note 12)   0 (2,511) (2,511)          
Redeemable Common Stock, Balance at Dec. 31, 2023 [1] 79,429                
Restricted stock granted 0             0  
Restricted stock granted, shares   65,525   65,525          
Exercise of stock options $ 48 $ 0     48     48  
Exercise of stock options, shares 15,832 15,832   15,832          
Stock-based compensation charge (Note 12) $ 2,202       2,202     2,202  
Reversal of stock-based compensation charge (Note 12) (112)       (112)     (112)  
Reversal of stock-based compensation charge (Note 12), shares   (55,539)   (55,539)          
Stock-based compensation charge related to equity-accounted investment (Note 5) 0       0     0  
Net loss (4,047)         (4,047)   (4,047) 0
Other comprehensive income (loss) (Note 11) $ (5,718)           (5,718) (5,718) 0
Balance, Number of Shares at Mar. 31, 2024 64,466,830 89,764,602 (25,297,772) 64,466,830          
Balance at Mar. 31, 2024 $ 173,087 $ 83 $ (288,445)   $ 341,287 $ 315,258 $ (195,096) $ 173,087 $ 0
Redeemable Common Stock, Balance at Mar. 31, 2024 $ 79,429                
[1]
(A) – Derived from audited financial statements